RNAZ

Transcode Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$8.70$-0.26 (-2.90%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence for RNAZ is being prepared.

Key Stats

Open

$8.66

Day High

$9.07

Day Low

$8.62

Prev Close

$8.96

Volume

Avg Volume

6.6K

Day Change

$-0.26

Change %

-2.90%

Fundamentals

P/B

2.52

EPS (TTM)

$-352.74

Market Cap

$8M

52-Wk Range

$6.08 — $22.03

What is P/E? →Stock fundamentals explained →

Earnings History

Insider Activity

Who Owns This Stock

Who Owns RNAZ

Dealer / Bank76.6%2 holders

Other23.4%4 holders

Based on Q4 2025 13F filings + AC behavioral model

6 institutional holders

Top Holders

1.★UBS Group AGdealer_bank

$19.7B

2.★Tower Research Capital LLC (TRC)other_unclassified

$6.1B

3.★UBS Group AGdealer_bank

$540M

4.SBI Securities Co., Ltd.other_unclassified

0.0%$68M

5.▲Bank of America Corpdealer_bank

+600.0%$48M

6.★OSAIC HOLDINGS, INC.other_unclassified

$20M

7.Bank of America Corpdealer_bank

0.0%$7M

8.★Royal Bank of Canadadealer_bank

$0K

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)

SELLINGBUYING

▲

Neutral

Dealer / Bank(76.6%)

●

Facilitating

Other(23.4%)

●

—

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

→Insider ActivityNo insider transactions in last 90 daysSEC Form 4

↑↑Analyst Consensus6 buy, 1 hold, 0 sellFinnhub

↑↑Inst. Flows6 increased/new, 0 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

No recent mentions of RNAZ on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.